{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:45:23Z","timestamp":1773297923615,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,10,23]],"date-time":"2016-10-23T00:00:00Z","timestamp":1477180800000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1111\/ijcp.12876","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T03:35:30Z","timestamp":1477280130000},"page":"843-852","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME)"],"prefix":"10.1155","volume":"70","author":[{"given":"Mario","family":"Maggi","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Biomedical Sciences; Sexual Medicine and Andrology Unit; University of Florence; Florence Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick C.W.","family":"Wu","sequence":"additional","affiliation":[{"name":"Andrology Research Unit; Centre for Endocrinology and Diabetes; Central Manchester University Hospitals NHS Foundation Trust; University of Manchester; Manchester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology; Barnsley Hospital NHS Foundation Trust; Barnsley UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Cardiology; London Bridge Hospital; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann M.","family":"Behre","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine and Andrology; Martin Luther University Halle-Wittenberg; Halle Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Hackett","sequence":"additional","affiliation":[{"name":"Holly Cottage Clinic; Lichfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Martin-Morales","sequence":"additional","affiliation":[{"name":"Carlos Haya University Hospital; Malaga Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Balercia","sequence":"additional","affiliation":[{"name":"Ospedali Riuniti - Ancona; Ancona Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian S.","family":"Dobs","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism; The Johns Hopkins University School of Medicine; Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan T.E.","family":"Arver","sequence":"additional","affiliation":[{"name":"Karolinska University Hospital; Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Maggio","sequence":"additional","affiliation":[{"name":"University of Parma; Parma Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn R.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Endocrinology; Baylor College of Medicine; Houston TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea M.","family":"Isidori","sequence":"additional","affiliation":[{"name":"Sapienza University of Rome; Rome Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Quinton","sequence":"additional","affiliation":[{"name":"Institute of Genetic Medicine; University of Newcastle-on-Tyne; Newcastle-on-Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia A.","family":"Wheaton","sequence":"additional","affiliation":[{"name":"New England Research Institutes, Inc.; Watertown MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora S.","family":"Siami","sequence":"additional","affiliation":[{"name":"New England Research Institutes, Inc.; Watertown MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond C.","family":"Rosen","sequence":"additional","affiliation":[{"name":"New England Research Institutes, Inc.; Watertown MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the RHYME Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,10,23]]},"reference":[{"key":"10.1111\/ijcp.12876-BIB0001|ijcp12876-cit-0001","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2014-1103","article-title":"Mortality associated to late-onset hypogonadism: reasons not to treat with testosterone?","volume":"99","author":"Kaufman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ijcp.12876-BIB0002|ijcp12876-cit-0002","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.mayocp.2014.10.011","article-title":"Testosterone therapy and cardiovascular risk: advances and controversies","volume":"90","author":"Morgentaler","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/ijcp.12876-BIB0003|ijcp12876-cit-0003","doi-asserted-by":"crossref","first-page":"207","DOI":"10.21037\/tau.2016.03.13","article-title":"Testosterone therapy in the new era of Food and Drug Administration oversight","volume":"5","author":"Desroches","year":"2016","journal-title":"Transl Androl Urol"},{"key":"10.1111\/ijcp.12876-BIB0004|ijcp12876-cit-0004","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ucl.2016.01.011","article-title":"Management of hypogonadism in cardiovascular patients: what are the implications of testosterone therapy on cardiovascular morbidity?","volume":"43","author":"Tanna","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1111\/ijcp.12876-BIB0005|ijcp12876-cit-0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.urology.2015.11.034","article-title":"Controversies and advances with testosterone therapy: a 40-year perspective","volume":"89","author":"Morgentaler","year":"2016","journal-title":"Urology"},{"key":"10.1111\/ijcp.12876-BIB0006|ijcp12876-cit-0006","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1111\/ijcp.12876-BIB0007|ijcp12876-cit-0007","doi-asserted-by":"crossref","first-page":"e85805","DOI":"10.1371\/journal.pone.0085805","article-title":"Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men","volume":"9","author":"Finkle","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1111\/ijcp.12876-BIB0008|ijcp12876-cit-0008","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12876-BIB0009|ijcp12876-cit-0009","unstructured":"FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use 2015 http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm436259.htm"},{"key":"10.1111\/ijcp.12876-BIB0010|ijcp12876-cit-0010","unstructured":"Agency of European Medicine No consistent evidence of an increased risk of heart problems with testosterone medicines 2014 2015-01-17; (EMA\/706140) http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/11\/news_detail_002218.jsp&mid=WC0b01ac058004d5c1"},{"key":"10.1111\/ijcp.12876-BIB0011|ijcp12876-cit-0011","unstructured":"Dohle GR Arver S Bettocchi C Guidelines on male hypogonadism 2015 http:\/\/uroweb.org\/wp-content\/uploads\/EAU-Guidelines-Male-Hypogonadism-2015.pdf"},{"key":"10.1111\/ijcp.12876-BIB0012|ijcp12876-cit-0012","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2015.11.003","article-title":"EMAS position statement: testosterone replacement therapy in the aging male","volume":"84","author":"Dimopoulou","year":"2016","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12876-BIB0013|ijcp12876-cit-0013","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.4158\/EP14434.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of testosterone and cardiovascular risk","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12876-BIB0014|ijcp12876-cit-0014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12876-BIB0015|ijcp12876-cit-0015","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.12876-BIB0016|ijcp12876-cit-0016","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.amjcard.2015.11.063","article-title":"Impact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated health care system","volume":"117","author":"Anderson","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12876-BIB0017|ijcp12876-cit-0017","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1111\/ijcp.12876-BIB0018|ijcp12876-cit-0018","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.chest.2016.05.007","article-title":"Association between testosterone replacement therapy and the incidence of deep vein thrombosis and pulmonary embolism: a retrospective cohort study of the Veterans Administration Database","volume":"150","author":"Sharma","year":"2016","journal-title":"Chest"},{"key":"10.1111\/ijcp.12876-BIB0019|ijcp12876-cit-0019","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/CIA.S32036","article-title":"Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)","volume":"7","author":"Bhattacharya","year":"2012","journal-title":"Clin Interv Aging"},{"key":"10.1111\/ijcp.12876-BIB0020|ijcp12876-cit-0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3810\/pgm.2013.03.2637","article-title":"12-month observation of testosterone replacement effectiveness in a general population of men","volume":"125","author":"Miner","year":"2013","journal-title":"Postgrad Med"},{"key":"10.1111\/ijcp.12876-BIB0021|ijcp12876-cit-0021","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/14740338.2014.950653","article-title":"Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis","volume":"13","author":"Corona","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/ijcp.12876-BIB0022|ijcp12876-cit-0022","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cen.13084","article-title":"Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a systematic review","volume":"85","author":"Albert","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/ijcp.12876-BIB0023|ijcp12876-cit-0023","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ijcp.12319","article-title":"Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study","volume":"68","author":"Traish","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12876-BIB0024|ijcp12876-cit-0024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0272.2008.00880.x","article-title":"Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men","volume":"41","author":"Haider","year":"2009","journal-title":"Andrologia"},{"key":"10.1111\/ijcp.12876-BIB0025|ijcp12876-cit-0025","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/j.orcp.2013.10.005","article-title":"Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study","volume":"8","author":"Haider","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"10.1111\/ijcp.12876-BIB0026|ijcp12876-cit-0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13685538.2013.765403","article-title":"Registry of hypogonadism in men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men","volume":"16","author":"Rosen","year":"2013","journal-title":"Aging Male"},{"key":"10.1111\/ijcp.12876-BIB0027|ijcp12876-cit-0027","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/13685538.2015.1004049","article-title":"Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men","volume":"18","author":"Lunenfeld","year":"2015","journal-title":"Aging Male"},{"key":"10.1111\/ijcp.12876-BIB0028|ijcp12876-cit-0028","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ijcp.12876-BIB0029|ijcp12876-cit-0029","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","article-title":"Cardiovascular disease in Europe: epidemiological update","volume":"36","author":"Nichols","year":"2015","journal-title":"Eur Heart"},{"key":"10.1111\/ijcp.12876-BIB0030|ijcp12876-cit-0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1756287215617648","article-title":"An update on the role of testosterone replacement therapy in the management of hypogonadism","volume":"8","author":"Hackett","year":"2016","journal-title":"Ther Adv Urol"},{"key":"10.1111\/ijcp.12876-BIB0031|ijcp12876-cit-0031","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/jc.2011-2591","article-title":"Testosterone treatment and mortality in men with low testosterone levels","volume":"97","author":"Shores","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ijcp.12876-BIB0032|ijcp12876-cit-0032","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/ijcp.12876-BIB0033|ijcp12876-cit-0033","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","article-title":"High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden","volume":"58","author":"Ohlsson","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12876-BIB0034|ijcp12876-cit-0034","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/ijcp.12864","article-title":"In Memoriam: Dr Graham Jackson, 1947-2016","volume":"70","author":"Cooper","year":"2016","journal-title":"International Journal of Clinical Practice"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12876","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12876","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.12876\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:09:54Z","timestamp":1643350194000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12876","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}